Back to Search
HAROLD KOEFFLER, M.D.
M.D.
Internal Medicine Physician
NPI: 1659309649Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
C035603(CA)
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
C035603(CA)
Research & Publications (20)
Vitamin D(2) analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome.
PMID 16164982·Leuk Res·2005
3-trial
Peroxisome proliferator-activated receptor gamma and cancers.
PMID 12538445·Clin Cancer Res·2003
6-review
Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
PMID 19620960·Nature·2009
7-preclinical
Blockade of MEK signaling potentiates 5-Aza-2'-deoxycytidine-induced apoptosis and upregulation of p21(waf1) in acute myelogenous leukemia cells.
PMID 19422044·Int J Cancer·2009
8-other
Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.
PMID 19605406·Cancer Res·2009
7-preclinical
Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array.
PMID 19477219·Exp Hematol·2009
8-other
Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy.
PMID 19278963·Haematologica·2009
8-other
High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
PMID 19435819·Mol Cancer Res·2009
8-other
Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia.
PMID 19424578·Int J Oncol·2009
8-other
Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.
PMID 19507250·Int J Cancer·2009
7-preclinical
A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies.
PMID 19421227·Leukemia·2009
8-other
Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.
PMID 19293402·J Leukoc Biol·2009
7-preclinical
Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
PMID 19670330·Int J Cancer·2009
8-other
Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype.
PMID 19144660·Haematologica·2009
8-other
Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis.
PMID 19133797·Clin Infect Dis·2009
8-other
Compound 48, a novel dual PPAR alpha/gamma ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib.
PMID 19131110·Leuk Res·2009
8-other
Induction of endoplasmic reticulum stress response by TZD18, a novel dual ligand for peroxisome proliferator-activated receptor alpha/gamma, in human breast cancer cells.
PMID 19671747·Mol Cancer Ther·2009
8-other
Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates.
PMID 19607716·BMC Genomics·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8700 BEVERLY BLVD.
LOS ANGELES, CA 90048 - Phone
- (310) 423-4609
Quick Facts
- NPI
- 1659309649
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile